Datavault AI expands PharmacyChain blockchain licensing deal with DataMeds AI to broader healthcare uses

Reuters2026/07/29 13:05

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Datavault AI expanded its PharmacyChain technology licensing deal with DataMeds AI to cover unencumbered commercial healthcare, healthspan, wellness applications.
Amended terms shift consideration to common shares equal to about 19.9% of DataMeds stock at closing, replacing preferred shares for tax optimization.
Closing remains tied to DataMeds completing related acquisitions, including two QOLPOM IP portfolios from EOS Technology Holdings.
Partnership targets patient-controlled healthcare data monetization, credentialing, blockchain-based data transactions, real-world asset tokenization across pharmacy, medical, lab, wearables settings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datavault Ai Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260729708218) on July 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Datavault AI expands PharmacyChain blockchain licensing deal with DataMeds AI to broader healthcare uses

You may also like

Crypto prices